|
End-of-day quote
Buenos Aires S.E.
2026-08-19
|
5-day change | 1st Jan Change | ||
| 23,320.00 ARS | +4.06% |
|
+6.00% | +39.89% |
| 08-19 | Argus Research Adjusts Amgen Price Target to $460 From $375, Maintains Buy Rating | MT |
| 08-19 | Morgan Stanley Adjusts Price Target on Amgen to $362 From $351, Keeps Equalweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 230B | |||||
| 1,093B | |||||
| 653B | - | - | - | ||
| 458B | |||||
| 355B | |||||
| 294B |
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
